Abbott restarts Similac infant formula production at Sturgis plant after six-month shutdown
date:Aug 30, 2022
on July 1 and later moved on to some metabolic formulas. Since then, the company notes a few batches containing the Cronobacter have been detected.

In those cases, we found the issue, addressed it, and no affected product has been or will be distributed. This confirms our quality systems work.

We make our products as if they were for our own families. Its important to us at Abbott that the public knows that the quality and safety of our products is our first priority, that we conduct microbi
6/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 10:21